Crown Reserve Acquisition Corp. I amends Carvix merger deal, extends outside date to Feb. 10, 2027
Crown Reserve Acquisition Corp. I (CRAC) and Carvix, Inc. signed a second amendment to their business combination agreement on September 23, 2026. The amendment moves the deadline after which either party may terminate the deal to the later of February 10, 2027 or the date required under the company's organizational documents, up from September 30, 2026. Shareholders should note that the deal timeline has been extended, and the transaction remains subject to shareholder approval and other closing conditions.
Key points
- Second Amendment to Business Combination Agreement signed September 23, 2026, following a First Amendment dated August 26, 2026.
- Outside Date extended to the later of February 10, 2027 and the date required under the company's pre-domestication organizational documents; previously September 30, 2026.
- Except as amended, the original business combination agreement dated March 30, 2026 remains in effect.
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 25, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.